GW-275175

N/A

Report date: 2025/03/21 11:07:50
NME

Base Information

Drug NameGW-275175
Drug Alias NameGW-275175GW-275175X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTerminase inhibitors
TargetsTerminase
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A